Tyrosinase ribonucleic acid (RNA) test predicts melanoma outcome
This article was originally published in Clinica
A test for tyrosinase messenger-RNA appears to predict progression in melanoma. Dr Uta Kunter of Hannover University in Germany believes tyrosinase is a marker of circulating melanoma cells and says a PCR-based test for the mRNA predicted outcome in a 64-patient study (Journal of the National Cancer Institute, May). There are currently no laboratory tests for melanoma prognosis.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.